Endo International Plc
(NASDAQ : ENDP)

( )
ENDP PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
0.00%24.2714.1%$215.51m
SHPGShire PLC Sponsored ADR
0.00%161.850.4%$146.66m
JAZZJazz Pharmaceuticals Plc
0.00%178.502.2%$132.60m
SAGESAGE Therapeutics, Inc.
0.00%153.469.6%$122.44m
ENDPEndo International Plc
0.00%9.488.9%$88.71m
PRGOPerrigo Co. Plc
0.15%75.766.7%$88.07m
ICPTIntercept Pharmaceuticals, Inc.
0.00%85.6721.8%$66.06m
MNKMallinckrodt Plc
0.00%19.2621.1%$57.13m
PTLAPortola Pharmaceuticals, Inc.
0.00%43.737.7%$53.35m
GWPHGW Pharmaceuticals PLC Sponsored ADR
0.06%151.347.6%$52.65m
SUPNSupernus Pharmaceuticals, Inc.
0.00%57.056.3%$41.50m
HZNPHorizon Pharma plc
0.00%17.677.5%$38.10m
UTHRUnited Therapeutics Corporation
0.00%116.4714.4%$36.89m
PBHPrestige Brands Holdings, Inc.
0.00%38.133.8%$29.30m
MDCOMedicines Company
0.00%36.2821.8%$28.34m

Company Profile

Endo International Plc operates as a pharmaceutical company. It focuses on developing, manufacturing, and distributing of branded and generic pharmaceutical products. The company operates through the following segments: U.S. Branded Pharmaceuticals, U.S. Generic pharmaceuticals and International Pharmaceuticals. The U.S. Branded Pharmaceuticals offers products that focus on the treatment and management of conditions in urology, urologic oncology, endocrinology, and orthopedics. The U.S. Generic pharmaceuticals segment consist of a differentiated product portfolio including high-barrier-to-entry products, first-to-file or first-to-market opportunities that are difficult to formulate, difficult to manufacture or face complex legal and regulatory challenges. The International Pharmaceuticals segment includes a variety of pharmaceutical products for the Canadian, Latin American, South African, and world markets. Endo International was founded in 1997 and is headquartered Dublin, Ireland.